NIH-funded research R01 grant

How specific T cells affect eye diseases and pain

Official title: Impact of tissue resident memory T cells on the neuro-immunepathophysiology of anterior eye disease

Funded at Dartmouth-Hitchcock Clinic · NIH-11047658 · Data updated 2026-11-12

This study is looking at how special immune cells in the eye, called tissue resident memory T cells, might be involved in causing and keeping eye problems like dry eye, and it hopes to find new ways to help people who suffer from ongoing eye pain.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDartmouth-Hitchcock Clinic
NIH-funded
Lab location1 site (Lebanon, United States)
Project startMarch 8, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$514,844
NIH project number5R01EY033712-04
Project IDNIH-11047658 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing persistent ocular pain due to anterior eye diseases, such as dry eye.

Less likely to help

Patients with anterior eye diseases who do not experience chronic pain may not benefit from this research.

What this research studies

This research investigates the role of a unique type of T cell, known as tissue resident memory T cells (TRM), in the development and persistence of anterior eye diseases like dry eye. By using a mouse model that mimics human conditions, the researchers aim to understand how these T cells interact with pain receptors in the eye and contribute to inflammation. The study will involve infecting mice with an ocular pathogen to create a more accurate representation of human TRM, allowing for targeted manipulation of these cells to assess their impact on ocular health. This approach could lead to new insights into treating persistent ocular pain.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from chronic eye pain and related conditions.

How similar studies have gone: While the specific approach of using TRM in this context is relatively novel, similar studies have shown promise in understanding immune responses in other conditions.

Where this research is happening

  • Dartmouth-Hitchcock Clinic
    Lebanon, United States
    Active

Researchers

  • Principal investigator: Skorput, Alexander — Dartmouth-Hitchcock Clinic
  • Study coordinator: Skorput, Alexander

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.